medical instruments
Tag details
Welcome to the 'medical instruments' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'medical instruments'.
Latest blogosphere posts tagged “medical instruments”
-
(BDX) Becton, Dickinson and Co Reports Strong Results
Stock Blog Hub —
Authority: 506
Becton, Dickinson and Co. ( BDX ) reported strong fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were $1.25, beating the Zacks Consensus Estimate by a cent and the year-ago earnings by 14 cents. For fiscal 2009, earnings per share came in at $4.95, which was below the Zacks ...1 day ago -
(ABMD) Abiomed, Inc’s Loss Narrower than Expected
Stock Blog Hub —
Authority: 506
Abiomed, Inc. ( ABMD ) reported fiscal second-quarter loss of 14 cents per share, considerably better than the Zacks Consensus Estimate of a loss of 21 cents. However, loss per share in the year-ago quarter was 8 cents. Total revenues in the reported quarter were roughly flat year over year at $20 million. In terms ...1 day ago -
Navilyst reportedly cuts 47 jobs at plant in Glens Falls
The Buzz: Business news —
Authority: 137
The Glens Falls Chronicle is reporting that Navilyst Medical, which took over the former Boston Scientific catheter plan in Glens Falls in December 2007, has eliminated the jobs of 47 workers there. Companywide, 51 jobs were eliminated, a spokeswoman told the Chronicle. The plant originally was operated by NAMIC USA. ...1 week ago -
(XRAY) Dentsply International Reports In-Line
Stock Blog Hub —
Authority: 506
Dentsply International Inc. ( XRAY ) reported third quarter earnings per share of 44 cents, in-line with the Zacks Consensus Estimate, but lower than the year-ago earnings of 46 cents. Net sales in the reported quarter increased 0.2% year over year to $531.0 million. Excluding the precious metal content, net sales ...1 week ago -
(PKI) PerkinElmer Tops Earnings Estimates
Stock Blog Hub —
Authority: 506
PerkinElmer Inc. ( PKI ) reported third-quarter earnings of 30 cents per share, which was 3 cents ahead of the Zacks Consensus Estimate. The company had earned 34 cents in the year-ago quarter. Revenues for the quarter came in at $437.1 million as against $478.7 million in the previous year period, a decline of ...1 week ago -
(CPTS) Conceptus, Inc. – Earnings Report Crushes Estimates
Stock Blog Hub —
Authority: 506
Conceptus, Inc. ( CPTS ) crushed analyst estimates after a very beneficial acquisition. Company Description Concept us makes a proprietary birth control product for women called Essure. The Essure procedure is permanent, done with out any incisions, and right in the doctor’s office. The procedure is available ...1 week ago -
(EVVV) ev3 Beats Consensus Earnings Estimates
Stock Blog Hub —
Authority: 506
ev3, Inc. ( EVVV ), the Zacks Bull of the Day for last Friday (October 23rd), reported third quarter 2009 earnings per share of 17 cents, easily beating the Zacks Consensus Estimate of 2 cents and the year-ago earnings of 4 cents. Sales Net sales in the reported quarter increased 5.4% year over year to $112.8 ...1 week ago -
(BDX) Becton-Dickinson and Company Set for Acquisition of HandyLab
Stock Blog Hub —
Authority: 506
Becton-Dickinson and Company ( BDX ) is set to acquire HandyLab Inc. , an Ann Arbor, Michigan-based company that develops and manufactures automation platforms and molecular diagnostic assays. The acquisition is expected to close by the year end. Financial terms of the deal have not been disclosed. Becton had ...1 week ago -
(ACL) Alcon Continues to Grow Pipeline
Stock Blog Hub —
Authority: 506
Alcon, Inc. ( ACL ) recently entered into an in-licensing agreement with Potentia Pharmaceuticals, a privately-held biotechnology company that focuses on the development of medicines for the treatment of age-related macular degeneration (AMD). Alcon gained the right to develop Potentia’s leading drug candidate, ...2 weeks ago -
(BCR) C.R. Bard Surpasses Consensus Estimates
Stock Blog Hub —
Authority: 506
C.R. Bard, Inc. (BCR) yesterday reported strong third quarter fiscal 2009 results after the market close. Earnings per share were $1.31, surpassing the Zacks Consensus Estimate of $1.27 and the year-ago earnings of $1.09. Sales Net sales in the quarter increased 3% year over year to $637.0 million. Excluding an ...2 weeks ago -
(CMN) Cantel Medical Corporation – Net Income Up 65%
Stock Blog Hub —
Authority: 506
Cantel Medical Corp (CMN) posted yet another earnings surprise with a 65% increase in net income. Company Description Cantel makes medical products to prevent and control infections. The products are sold globally and range from water purification to disposable items like masks, wipes, and other products. Net ...2 weeks ago -
(CMN) Cantel Medical Corporation – Fighting Swine Flu – Net Income Up 65%
Stock Blog Hub —
Authority: 506
Cantel Medical Corp (CMN) posted yet another earnings surprise with a 65% increase in net income. Company Description Cantel makes medical products to prevent and control infections. The products are sold globally and range from water purification to disposable items like masks, wipes, and other products. Net ...2 weeks ago -
(BAX) Baxter International Eyes Swine Flu Market
Stock Blog Hub —
Authority: 506
Baxter International Inc. (BAX) announced that it sees multiyear opportunity in H1N1 vaccines, commonly known as Swine Flu vaccines. The company expects to recognize $30 million to $40 million in revenues from swine flu vaccines in the fourth quarter. Baxter has not speculated on H1N1 vaccine sales beyond the fourth ...2 weeks ago -
(BSX) Boston Scientific Corporation Surpasses Estimates
Stock Blog Hub —
Authority: 506
Boston Scientific Corporation (BSX) yesterday reported financial results for the third quarter of fiscal 2009 after the market close. Earnings per share were 19 cents, beating the Zacks Consensus Estimate by 5 cents and the year-ago earnings by 3 cents. Sales Net sales in the quarter were $2.0 billion, ...2 weeks ago -
(TSON) TranS1 Trims Third Quarter Outlook
Stock Blog Hub —
Authority: 506
TranS1 Inc. (TSON) has announced that it expects revenues to be approximately $6.8 million to $6.9 million in the third quarter of 2009 compared to $6 million reported in the year-ago quarter. Results for the quarter are expected to be released on Oct 29, 2009. While revenues are expected to increase from the ...3 weeks ago -
(COV) Covidien Limited – Earnings Surprise Streak Broken
Stock Blog Hub —
Authority: 506
Covidien Limited (COV) has surprised on estimates 3 out of the last 4 quarters. The company also recently raised its dividend. Covidien is trading at 13.6x forward earnings. Company Description Covidien manufactures medical devices, medical supplies and imaging solutions. It has pioneered the use of contrast ...3 weeks ago -
(BAX) Baxter International Beats Earnings, Raises Outlook
Stock Blog Hub —
Authority: 506
Baxter International Inc. (BAX) today reported third quarter fiscal 2009 earnings per share of 98 cents, surpassing the Zacks Consensus Estimate of 97 cents and the year-ago earnings of 88 cents. The company also raised its outlook for full fiscal 2009. Sales Net sales in the quarter were roughly flat year over ...3 weeks ago -
(BDX) Becton, Dickinson and Co. Receives FDA Approval on Blood Collection Device
Stock Blog Hub —
Authority: 506
Becton, Dickinson and Co. (BDX) announced that it received Food and Drug Administration (FDA) approval to market its blood collection device, BD Vacutainer Rapid Serum Tube, in the U.S. Unlike standard tubes, the Serum tubes are ready for analysis in five minutes. The Serum tube contains a gel additive that speeds ...3 weeks ago -
(BSX) Boston Scientific Corporation Settles Patent Infringement With Johnson & Johnson
Stock Blog Hub —
Authority: 506
Boston Scientific Corporation (BSX) yesterday announced that it will settle fourteen patent infringement lawsuits against Johnson & Johnson (JNJ) related to the use of stents in treating heart disease for $716.3 million. The company will make use of cash held in its legal reserve to make the payment. The ...5 weeks ago -
(BAX) Baxter International – Bullish Earnings Projections
Stock Blog Hub —
Authority: 506
Baxter International (BAX) is seeing bullish earnings projections. The current full-year Zacks Consensus Estimate of $3.79 per share was increased from $3.77 over the past 3 months. For 2010, the forecast jumped from $4.24 to $4.28 over the same time frame. Company Description Baxter International develops, ...5 weeks ago
